Trial · NCT01441102
Outcomes17
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage Change in Retinal Thickness in the Study Eye at 6 Months Compared to Baseline | Baseline and 6 months | Two participants withdrew from the study prior to the 6-month visit. | percentage change in retinal thickness | MEAN |
| SECONDARY | Percentage Change in Retinal Thickness in the Study Eye at 12 Months Compared to Baseline | Baseline and 12 Months | percentage change in retinal thickness | MEAN | |
| SECONDARY | Percentage Change in Retinal Thickness in the Study Eye at 18 Months Compared to Baseline | Baseline and 18 Months | percentage change in retinal thickness | MEAN | |
| SECONDARY | Percentage Change in Retinal Thickness in the Study Eye at 24 Months Compared to Baseline | Baseline and 24 Months | percentage change in retinal thickness | MEAN | |
| SECONDARY | Change in Best-corrected Visual Acuity (BCVA) in the Study Eye at 6 Months Compared to Baseline | Baseline and 6 Months | Two participants withdrew from the study prior to the 6-month visit. | ETDRS letters | MEAN |
| SECONDARY | Change in Best-corrected Visual Acuity (BCVA) in the Study Eye at 12 Months Compared to Baseline | Baseline and 12 Months | ETDRS letters | MEAN | |
| SECONDARY | Change in Best-corrected Visual Acuity (BCVA) in the Study Eye at 18 Months Compared to Baseline | Baseline and 18 Months | ETDRS letters | MEAN | |
| SECONDARY | Change in Best-corrected Visual Acuity (BCVA) in the Study Eye at 24 Months Compared to Baseline | Baseline and 24 Months | ETDRS letters | MEAN | |
| SECONDARY | Number of Study Eyes Demonstrating a Decrease in the Area of Late Leakage, as Measured by Fluorescein Angiography (FA), at 6 Months Compared to Baseline | Baseline and 6 Months | eyes | NUMBER | |
| SECONDARY | Number of Study Eyes Demonstrating a Decrease in the Area of Late Leakage, as Measured by Fluorescein Angiography (FA), at 12 Months Compared to Baseline | Baseline and 12 Months | eyes | NUMBER | |
| SECONDARY | Number of Study Eyes Demonstrating a Decrease in the Area of Late Leakage, as Measured by Fluorescein Angiography (FA), at 18 Months Compared to Baseline | Baseline and 18 Months | eyes | NUMBER | |
| SECONDARY | Number of Study Eyes Demonstrating a Decrease in the Area of Late Leakage, as Measured by Fluorescein Angiography (FA), at 24 Months Compared to Baseline | Baseline and 24 Months | eyes | NUMBER | |
| SECONDARY | Changes in Mean Macular Sensitivity in the Study Eye at 6 Months Compared to Baseline | Baseline and 6 Months | dB | MEAN | |
| SECONDARY | Changes in Mean Macular Sensitivity in the Study Eye at 12 Months Compared to Baseline | Baseline and 12 Months | dB | MEAN | |
| SECONDARY | Changes in Mean Macular Sensitivity in the Study Eye at 18 Months Compared to Baseline | Baseline and 18 Months | dB | MEAN | |
| SECONDARY | Changes in Mean Macular Sensitivity in the Study Eye at 24 Months Compared to Baseline | Baseline and 24 Months | dB | MEAN | |
| SECONDARY | Number of Participants Withdrawn From the Study Therapy Due to Vision Loss or Adverse Events | Duration of the study, up to 24 months | participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01441102/outcomes